5-amino-1mq nnmt inhibitor studies 50mg (60 Capsules) 5-Amino-1MQ 50mg | NNMT Inhibitor
Description
In preclinical heart failure models, NNMT enzyme inhibition markedly reduced cardiac 1-MNA (by 77.1%), improved cardiac function, reduced left ventricular hypertrophy and fibrosis, and decreased pro-inflammatory gene expression
They are compounded by licensed pharmacies under provider supervision
Pricing varies significantly based on batch size, third-party testing, and supplier sourcing practices
It has been explored for the treatment of neurodegenerative diseases
